| | |
ASPsiRNA information |
siRNA Id: | aspsirna2119
|
siRNA Name: | 11
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | ACCAUCAACCUCGACCACC
|
ASP-siRNA (As strand 3'->5'): | ACCAUCAACCUCGACAACC
|
Mismatch position in siRNA: | A4C |
Gene Information |
Gene Name | K-RAS (KRAS) |
Target Sequence (5'->3'): | gaatataaacttgtggtagttggagctggtggcgtaggcaagagtgccttgacgatacagctaattcagaatcattt
|
Wild allele (5'->3'): | UGGUAGUUGGAGCUGGUGG
|
Mutant allele (5'->3'): | UGGUAGUUGGAGCUGUUGG
|
Position of siRNA on target gene: | 212-230
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_033360.3 |
Cytogenic location: | 12p12.1 |
Chromosomal coordinates: | 12:25,358,179-25,403,869 |
UniProt ID: | P01116 |
HUGO ID: | 6407 |
Reference SNp(RefSNP): | rs12191352 |
Disease/Mutation information |
Target Mutation: | c.35G>T,p.Gly12Val
|
Matation type/variant: | single nucleotide variant/missense variant
|
Mutation at gene level: | NG_007524.1:g.10571G>T
|
Pathogenic status of mutation: | NA
|
Disease: | Cancer |
Clinical Resources |
ClinVar ID: | 12583 |
KEGG disease ID: | H00003 |
OMIM ID: | 190070 |
COSMIC: | KRAS |
DECIPHER: | KRAS |
GeneTests: | KRAS |
ASP siRNA details |
Mutant allele (5'->3'): | UGGUAGUUGGAGCUGUUGG
|
ASP-siRNA (As strand 3'->5'): | ACCAUCAACCUCGACAACC
|
Percentage efficacy of ASP-siRNA for mutant allele: | 5
|
Wild allele (5'->3'): | UGGUAGUUGGAGCUGGUGG
|
ASP-siRNA (As strand 3'->5'): | ACCAUCAACCUCGACAACC
|
Percentage efficacy of ASP-siRNA for wild allele: | 0
|
Relative difference: | 5
|
Wild siRNA details |
Wild allele (5'->3'): | UGGUAGUUGGAGCUGGUGG
|
Wild siRNA (As strand 3'->5'): | ACCAUCAACCUCGACCACC
|
Percentage efficacy of wild siRNA for wild allele: | 67
|
Wild allele (5'->3'): | UGGUAGUUGGAGCUGGUGG
|
ASP-siRNA (As strand 3'->5'): | ACCAUCAACCUCGACAACC
|
Percentage efficacy of Wild sirna for mutant allele: | 23
|
Relative difference : | 44
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | HeLa |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Dharmacon |
Post-transfection duration: | 24 hours |
Concentration used: | 100nM |
Reference: | US2005/0176045A1 |
Delivery method: | Transfection |
'Article title: | SNP discriminatory siRNA |
'Authors: | Yuriy Fedorov, Angela Reynolds, Anastasia Khvorova |
'Journal Reference: | US20050176045 A1 |
'